Armata Pharmaceuticals Ratios (2013-2018) | ARMP

Ratios Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018
Profitability
EBT Margin -6,495.45%-1,991.08%-78,333.33%1,026.19%-10,872.12%-3,710.89%-5,078.64%-2,571.29%-2,645.10%-2,541.18%-1,607.69%-2,296.88%-4,262.26%-3,021.36%-8,189.66%-45,709.09%-11,586.21%-11,592.86%-2,050.00%-11,760.00%10,980.68%902.61%326.71%
EBIT Margin -6,059.09%-1,950.32%-78,033.33%1,026.19%-2,436.54%-3,710.89%-5,078.64%-2,571.29%-2,222.55%-2,541.18%-1,697.90%-2,296.88%-4,262.26%-3,484.47%-11,748.28%-53,927.27%-11,582.76%-34,592.86%-1,963.16%-11,825.00%10,901.14%791.21%829.08%
EBITDA Margin -7,872.73%-4,030.25%-1,464,033.33%-297.22%-11,570.19%15,234.65%18,733.01%-2,571.29%-2,222.55%-2,541.18%-1,697.90%-2,296.88%-4,262.26%-3,484.47%-11,748.28%-53,927.27%-11,582.76%-34,592.86%-1,963.16%-11,825.00%10,980.68%902.61%326.71%
Operating Margin -6,059.09%-1,950.32%-78,033.33%1,026.19%-2,436.54%-3,710.89%-5,078.64%-2,571.29%-2,222.55%-2,541.18%-1,697.90%-2,296.88%-4,262.26%-3,484.47%-11,748.28%-53,927.27%-11,582.76%-34,592.86%-1,963.16%-11,825.00%10,901.14%791.21%829.08%
Net Margin -7,477.27%-4,696.18%-1,634,633.33%-90.87%-11,174.04%9,296.04%14,070.87%-984.16%-14,540.20%8,765.69%-1,205.59%-2,484.38%-4,563.21%-6,165.05%-12,375.86%-43,181.82%-11,193.10%-28,717.86%-2,050.00%-11,650.00%3,561.36%529.97%2,644.51%
FCF Margin -5,086.36%-424.20%-84,200.00%562.30%-3,769.23%-3,846.53%-2,683.50%-3,173.27%-2,294.12%-2,618.63%-1,827.27%-1,849.22%-3,016.04%-2,929.13%-10,896.55%-6,868.18%-11,393.10%-10,475.00%-1,647.37%-11,935.00%2,131.82%708.47%1,064.09%
Efficiency
Assets Average 39.38M36.14M33.33M30.27M33.61M37.49M35.23M32.79M29.88M28.77M27.66M22.09M16.23M14.70M14.44M12.46M12.77M13.06M11.17M
Equity Average -28.32M-25.97M-6.78M3.90M0.18M5.01M14.38M14.19M10.81M15.19M19.86M13.98M8.19M8.25M9.81M8.74M208.10M210.01M10.18M
Invested Capital -22.62M-34.01M-17.92M4.37M3.44M-3.08M13.09M15.66M12.71M8.90M21.48M18.23M9.72M6.65M9.86M9.76M7.73M408.46M11.56M8.80M
Asset Utilization Ratio 0.000.000.000.010.010.010.010.010.020.020.010.010.010.010.010.010.00-0.03
Leverage & Solvency
Interest Coverage Ratio -13.89-47.84-260.11-0.29-5.2618.82-36.28-0.00M-109.01-7.91-8.29
Equity Ratio -0.55-0.91-0.520.140.12-0.080.360.460.400.310.730.700.540.460.650.710.6928.370.990.83
Times Interest Earned -13.89-47.84-260.11-0.29-5.2618.82-36.28-0.00M-109.01-7.91-8.29
Dividends & Payouts
FCF Payout Ratio -0.01
Valuation
Enterprise Value 1.55M-3.67M5.67M80.04M-4.46M41.73M31.39M71.24M39.52M39.15M20.09M14.05M9.82M13.98M12.94M-0.24M4.89M-3.79M0.24M4.46M11.22M3.18M-3.71M6.78M
Market Capitalization 2.27M3.72M10.53M100.40M11.98M54.28M41.17M77.83M56.15M53.50M31.83M23.42M15.99M21.13M16.90M4.89M7.09M5.17M7.96M9.59M19.43M18.60M9.69M6.78M
Return Ratios
Return on Sales -145.02%-133.11%454.34%-408.43%-55.95%-35.07%-32.15%-22.74%-22.01%-25.63%-26.66%-35.17%-77.16%-103.30%-176.27%-149.07%-84.67%46.19%22.31%
Return on Capital Employed -0.35%-0.33%-0.46%-0.50%-0.44%-0.36%-0.30%-0.34%-0.46%-0.53%-0.59%-1.26%-1.66%-2.58%-2.14%-1.54%-2.03%-1.74%
Return on Assets -0.57%-0.55%-0.69%-0.76%-0.42%-0.35%-0.29%-0.32%-0.41%-0.44%-0.47%-0.91%-1.16%-1.29%-1.21%-0.78%-1.23%-1.39%
Return on Equity 0.79%0.77%3.37%-5.86%-79.08%-2.62%-0.71%-0.74%-1.14%-0.84%-0.65%-1.44%-2.31%-2.31%-1.78%-1.11%-0.08%-1.53%